|Age Group||50 - 99 years
|Research Start Date||August 1, 2006
|Research End Date||July 31, 2013
|Principal Investigator||Frances Johnson, MD
The purpose of this study is to evaluate the effectiveness of aldosterone antagonist therapy in reducing all cause mortality in patients who have heart failure with preserved systolic function.
This study is closed to enrollment and in the follow-up phase.
Please refer to www.clinicaltrials.gov identifier NCT00094302 for more information.
| Contact Info ||
Cardiomyopathy Treatment Program
Page Scovel, RN
|Keywords||span itemProp='description'>Cardiac disease ; Cardiomyopathy ; CHF ; Congestive heart failure ; Diastolic dysfunction ; Heart ; Heart Failure ; Preserved systolic function ;